Director, US Value, Access, and Pricing Strategy
Orca BioFull Time
Senior (5 to 8 years)
Remote
Candidates must have proven experience in market access, pricing strategy, or health economics within the life sciences industry. A strong understanding of payer dynamics, reimbursement pathways, and value-based contracting models is essential. Exceptional communication skills are required to synthesize complex data into clear, actionable insights. Demonstrated success in client engagement, strategic planning, and cross-functional collaboration is necessary. The ability to lead high-visibility projects and influence senior stakeholders is also required. An advanced degree in health policy, business, life sciences, or a related field is preferred.
The Senior Director, Value & Access will serve as a senior advisor and strategic leader, guiding clients through complex market access challenges in the life sciences sector. This role is responsible for developing and executing innovative access strategies informed by deep marketplace knowledge and payer insights. The Senior Director will collaborate closely with account leads, consultants, and business development teams to deliver actionable solutions that drive product access and commercial success. Key responsibilities include leading the design and implementation of market access strategies across pricing, contracting, reimbursement, and value-based frameworks, providing expert assessments of therapeutic value, and overseeing project delivery by offering strategic direction, developing content, and reviewing client-facing materials. The role also involves conducting market access landscape evaluations, competitor simulations, and payer engagement strategies, developing communications tailored to healthcare decision-makers and stakeholders, and supporting business development efforts by contributing to sales strategy, refining presentation content, and engaging with prospective clients.
Healthcare consulting for drug development support
The Lockwood Group provides consulting services specifically for the healthcare and pharmaceutical industries, focusing on clients in the later stages of drug development, particularly after Phase 2 clinical trials. The company assists pharmaceutical and biotech firms by creating strategic publication plans that communicate scientific data and research findings accurately and in compliance with regulatory standards. They also support clients during the prelaunch phase of their products by identifying market needs and collaborating through the launch process to ensure success. A unique aspect of The Lockwood Group is its medical animation affiliate, Random42, which produces engaging and scientifically accurate visual content to help convey complex information. Their business model is based on service fees for consulting and project work, with a commitment to delivering high-quality communications and strategic support to help clients thrive in the competitive healthcare landscape.